nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—SLC22A7—Fluorouracil—head and neck cancer	0.146	0.291	CbGbCtD
Valproic Acid—SLC22A7—Docetaxel—head and neck cancer	0.112	0.222	CbGbCtD
Valproic Acid—CYP2A6—Fluorouracil—head and neck cancer	0.0829	0.165	CbGbCtD
Valproic Acid—CYP2C8—Fluorouracil—head and neck cancer	0.0409	0.0814	CbGbCtD
Valproic Acid—CYP3A5—Docetaxel—head and neck cancer	0.0325	0.0647	CbGbCtD
Valproic Acid—CYP1A2—Fluorouracil—head and neck cancer	0.0317	0.063	CbGbCtD
Valproic Acid—CYP2C9—Fluorouracil—head and neck cancer	0.0285	0.0568	CbGbCtD
Valproic Acid—CYP3A4—Vinblastine—head and neck cancer	0.0154	0.0306	CbGbCtD
Valproic Acid—CYP3A4—Docetaxel—head and neck cancer	0.0127	0.0252	CbGbCtD
Valproic Acid—UGT1A8—tongue—head and neck cancer	0.00668	0.0784	CbGeAlD
Valproic Acid—HDAC2—parathyroid gland—head and neck cancer	0.00531	0.0623	CbGeAlD
Valproic Acid—UGT1A8—mouth—head and neck cancer	0.00449	0.0527	CbGeAlD
Valproic Acid—OGDH—mouth—head and neck cancer	0.00418	0.049	CbGeAlD
Valproic Acid—UGT1A4—mouth—head and neck cancer	0.0034	0.04	CbGeAlD
Valproic Acid—HDAC2—tongue—head and neck cancer	0.0028	0.0328	CbGeAlD
Valproic Acid—OGDH—connective tissue—head and neck cancer	0.00256	0.03	CbGeAlD
Valproic Acid—HDAC2—exocrine gland—head and neck cancer	0.00252	0.0295	CbGeAlD
Valproic Acid—HDAC2—hair follicle—head and neck cancer	0.0024	0.0282	CbGeAlD
Valproic Acid—ACADSB—parotid gland—head and neck cancer	0.00231	0.0271	CbGeAlD
Valproic Acid—ACADSB—saliva-secreting gland—head and neck cancer	0.00221	0.026	CbGeAlD
Valproic Acid—OGDH—trachea—head and neck cancer	0.00215	0.0252	CbGeAlD
Valproic Acid—HDAC9—trachea—head and neck cancer	0.00189	0.0222	CbGeAlD
Valproic Acid—HDAC2—mouth—head and neck cancer	0.00188	0.0221	CbGeAlD
Valproic Acid—OGDH—lymphoid tissue—head and neck cancer	0.00187	0.022	CbGeAlD
Valproic Acid—ACADSB—trachea—head and neck cancer	0.00171	0.02	CbGeAlD
Valproic Acid—OGDH—thyroid gland—head and neck cancer	0.0017	0.0199	CbGeAlD
Valproic Acid—HDAC9—lymphoid tissue—head and neck cancer	0.00165	0.0194	CbGeAlD
Valproic Acid—UGT1A8—head—head and neck cancer	0.00162	0.019	CbGeAlD
Valproic Acid—HDAC2—neck—head and neck cancer	0.00161	0.0189	CbGeAlD
Valproic Acid—OGDH—head—head and neck cancer	0.00151	0.0177	CbGeAlD
Valproic Acid—HDAC9—thyroid gland—head and neck cancer	0.0015	0.0176	CbGeAlD
Valproic Acid—ACADSB—thyroid gland—head and neck cancer	0.00135	0.0158	CbGeAlD
Valproic Acid—HDAC9—head—head and neck cancer	0.00133	0.0156	CbGeAlD
Valproic Acid—ALDH5A1—lymphoid tissue—head and neck cancer	0.00131	0.0154	CbGeAlD
Valproic Acid—HDAC2—saliva-secreting gland—head and neck cancer	0.00126	0.0147	CbGeAlD
Valproic Acid—ALDH5A1—thyroid gland—head and neck cancer	0.00119	0.014	CbGeAlD
Valproic Acid—HDAC2—connective tissue—head and neck cancer	0.00115	0.0135	CbGeAlD
Valproic Acid—HDAC2—epithelium—head and neck cancer	0.0011	0.0129	CbGeAlD
Valproic Acid—OGDH—lymph node—head and neck cancer	0.00106	0.0124	CbGeAlD
Valproic Acid—ALDH5A1—head—head and neck cancer	0.00105	0.0124	CbGeAlD
Valproic Acid—ABAT—thyroid gland—head and neck cancer	0.00102	0.0119	CbGeAlD
Valproic Acid—Face oedema—Hydroxyurea—head and neck cancer	0.00101	0.00443	CcSEcCtD
Valproic Acid—Pleural effusion—Docetaxel—head and neck cancer	0.000979	0.00429	CcSEcCtD
Valproic Acid—Photophobia—Fluorouracil—head and neck cancer	0.000975	0.00428	CcSEcCtD
Valproic Acid—SLC16A1—epithelium—head and neck cancer	0.000973	0.0114	CbGeAlD
Valproic Acid—Hepatotoxicity—Docetaxel—head and neck cancer	0.000971	0.00426	CcSEcCtD
Valproic Acid—Otitis media—Docetaxel—head and neck cancer	0.000963	0.00422	CcSEcCtD
Valproic Acid—Necrosis—Docetaxel—head and neck cancer	0.000955	0.00419	CcSEcCtD
Valproic Acid—Coma—Fluorouracil—head and neck cancer	0.000949	0.00416	CcSEcCtD
Valproic Acid—Breast disorder—Hydroxyurea—head and neck cancer	0.000946	0.00415	CcSEcCtD
Valproic Acid—Rash maculo-papular—Fluorouracil—head and neck cancer	0.000944	0.00414	CcSEcCtD
Valproic Acid—Pancytopenia—Vinblastine—head and neck cancer	0.000943	0.00413	CcSEcCtD
Valproic Acid—HDAC9—lymph node—head and neck cancer	0.000931	0.0109	CbGeAlD
Valproic Acid—ABAT—head—head and neck cancer	0.000902	0.0106	CbGeAlD
Valproic Acid—Euphoric mood—Fluorouracil—head and neck cancer	0.000892	0.00391	CcSEcCtD
Valproic Acid—Pancreatitis—Hydroxyurea—head and neck cancer	0.000887	0.00389	CcSEcCtD
Valproic Acid—Depression—Vinblastine—head and neck cancer	0.000882	0.00387	CcSEcCtD
Valproic Acid—Pancytopenia—Hydroxyurea—head and neck cancer	0.00086	0.00377	CcSEcCtD
Valproic Acid—Photosensitivity—Fluorouracil—head and neck cancer	0.000858	0.00376	CcSEcCtD
Valproic Acid—Swelling—Fluorouracil—head and neck cancer	0.000854	0.00375	CcSEcCtD
Valproic Acid—Amenorrhoea—Docetaxel—head and neck cancer	0.000853	0.00374	CcSEcCtD
Valproic Acid—Dysuria—Hydroxyurea—head and neck cancer	0.000846	0.00371	CcSEcCtD
Valproic Acid—Neutropenia—Hydroxyurea—head and neck cancer	0.000846	0.00371	CcSEcCtD
Valproic Acid—HDAC2—lymphoid tissue—head and neck cancer	0.000843	0.0099	CbGeAlD
Valproic Acid—ACADSB—lymph node—head and neck cancer	0.000839	0.00984	CbGeAlD
Valproic Acid—Agranulocytosis—Vinblastine—head and neck cancer	0.000826	0.00362	CcSEcCtD
Valproic Acid—Weight increased—Hydroxyurea—head and neck cancer	0.000824	0.00361	CcSEcCtD
Valproic Acid—Drug interaction—Docetaxel—head and neck cancer	0.000808	0.00354	CcSEcCtD
Valproic Acid—Drowsiness—Hydroxyurea—head and neck cancer	0.000807	0.00354	CcSEcCtD
Valproic Acid—Amnesia—Fluorouracil—head and neck cancer	0.000802	0.00352	CcSEcCtD
Valproic Acid—Haemoglobin—Vinblastine—head and neck cancer	0.000798	0.0035	CcSEcCtD
Valproic Acid—Haemorrhage—Vinblastine—head and neck cancer	0.000794	0.00348	CcSEcCtD
Valproic Acid—Hypoaesthesia—Vinblastine—head and neck cancer	0.00079	0.00347	CcSEcCtD
Valproic Acid—Dermatitis bullous—Fluorouracil—head and neck cancer	0.000789	0.00346	CcSEcCtD
Valproic Acid—Pharyngitis—Vinblastine—head and neck cancer	0.000788	0.00346	CcSEcCtD
Valproic Acid—Hearing impaired—Docetaxel—head and neck cancer	0.000787	0.00345	CcSEcCtD
Valproic Acid—Stomatitis—Hydroxyurea—head and neck cancer	0.000787	0.00345	CcSEcCtD
Valproic Acid—Bone pain—Docetaxel—head and neck cancer	0.000782	0.00343	CcSEcCtD
Valproic Acid—Lethargy—Fluorouracil—head and neck cancer	0.000769	0.00337	CcSEcCtD
Valproic Acid—HDAC2—thyroid gland—head and neck cancer	0.000766	0.00899	CbGeAlD
Valproic Acid—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000763	0.00335	CcSEcCtD
Valproic Acid—Osteoarthritis—Fluorouracil—head and neck cancer	0.000754	0.00331	CcSEcCtD
Valproic Acid—Injection site reaction—Docetaxel—head and neck cancer	0.000745	0.00327	CcSEcCtD
Valproic Acid—ALDH5A1—lymph node—head and neck cancer	0.000738	0.00867	CbGeAlD
Valproic Acid—Haemoglobin—Hydroxyurea—head and neck cancer	0.000728	0.00319	CcSEcCtD
Valproic Acid—Influenza like illness—Docetaxel—head and neck cancer	0.000728	0.00319	CcSEcCtD
Valproic Acid—Haemorrhage—Hydroxyurea—head and neck cancer	0.000724	0.00318	CcSEcCtD
Valproic Acid—Hallucination—Hydroxyurea—head and neck cancer	0.000721	0.00316	CcSEcCtD
Valproic Acid—Ataxia—Fluorouracil—head and neck cancer	0.000709	0.00311	CcSEcCtD
Valproic Acid—Alopecia—Vinblastine—head and neck cancer	0.000702	0.00308	CcSEcCtD
Valproic Acid—Dry skin—Fluorouracil—head and neck cancer	0.000691	0.00303	CcSEcCtD
Valproic Acid—SLC16A1—thyroid gland—head and neck cancer	0.000681	0.00799	CbGeAlD
Valproic Acid—HDAC2—head—head and neck cancer	0.00068	0.00798	CbGeAlD
Valproic Acid—Neoplasm—Docetaxel—head and neck cancer	0.000678	0.00297	CcSEcCtD
Valproic Acid—SLC22A5—parotid gland—head and neck cancer	0.000665	0.00781	CbGeAlD
Valproic Acid—Muscular weakness—Fluorouracil—head and neck cancer	0.000665	0.00292	CcSEcCtD
Valproic Acid—Angiopathy—Hydroxyurea—head and neck cancer	0.000657	0.00288	CcSEcCtD
Valproic Acid—Dysphagia—Fluorouracil—head and neck cancer	0.000652	0.00286	CcSEcCtD
Valproic Acid—Chills—Hydroxyurea—head and neck cancer	0.00065	0.00285	CcSEcCtD
Valproic Acid—Eosinophilia—Fluorouracil—head and neck cancer	0.000645	0.00283	CcSEcCtD
Valproic Acid—Ill-defined disorder—Vinblastine—head and neck cancer	0.000642	0.00281	CcSEcCtD
Valproic Acid—Alopecia—Hydroxyurea—head and neck cancer	0.00064	0.00281	CcSEcCtD
Valproic Acid—Anaemia—Vinblastine—head and neck cancer	0.000639	0.0028	CcSEcCtD
Valproic Acid—SLC22A5—saliva-secreting gland—head and neck cancer	0.000637	0.00748	CbGeAlD
Valproic Acid—ABAT—lymph node—head and neck cancer	0.000632	0.00741	CbGeAlD
Valproic Acid—Malaise—Vinblastine—head and neck cancer	0.000624	0.00273	CcSEcCtD
Valproic Acid—Vertigo—Vinblastine—head and neck cancer	0.000621	0.00272	CcSEcCtD
Valproic Acid—Leukopenia—Vinblastine—head and neck cancer	0.000619	0.00271	CcSEcCtD
Valproic Acid—Pancytopenia—Fluorouracil—head and neck cancer	0.000619	0.00271	CcSEcCtD
Valproic Acid—Swelling—Docetaxel—head and neck cancer	0.000617	0.0027	CcSEcCtD
Valproic Acid—Deafness—Docetaxel—head and neck cancer	0.000608	0.00267	CcSEcCtD
Valproic Acid—Hepatic failure—Docetaxel—head and neck cancer	0.000605	0.00265	CcSEcCtD
Valproic Acid—SLC16A1—head—head and neck cancer	0.000604	0.00709	CbGeAlD
Valproic Acid—Hypertension—Vinblastine—head and neck cancer	0.000597	0.00262	CcSEcCtD
Valproic Acid—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000595	0.00261	CcSEcCtD
Valproic Acid—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000585	0.00257	CcSEcCtD
Valproic Acid—Pneumonia—Fluorouracil—head and neck cancer	0.000584	0.00256	CcSEcCtD
Valproic Acid—Anaemia—Hydroxyurea—head and neck cancer	0.000583	0.00256	CcSEcCtD
Valproic Acid—Discomfort—Vinblastine—head and neck cancer	0.000582	0.00255	CcSEcCtD
Valproic Acid—Dermatitis bullous—Docetaxel—head and neck cancer	0.000569	0.0025	CcSEcCtD
Valproic Acid—Malaise—Hydroxyurea—head and neck cancer	0.000569	0.00249	CcSEcCtD
Valproic Acid—Stomatitis—Fluorouracil—head and neck cancer	0.000566	0.00248	CcSEcCtD
Valproic Acid—Urinary tract infection—Fluorouracil—head and neck cancer	0.000565	0.00248	CcSEcCtD
Valproic Acid—Conjunctivitis—Fluorouracil—head and neck cancer	0.000565	0.00248	CcSEcCtD
Valproic Acid—Leukopenia—Hydroxyurea—head and neck cancer	0.000565	0.00248	CcSEcCtD
Valproic Acid—Lethargy—Docetaxel—head and neck cancer	0.000555	0.00243	CcSEcCtD
Valproic Acid—Thrombocytopenia—Vinblastine—head and neck cancer	0.000553	0.00242	CcSEcCtD
Valproic Acid—Epistaxis—Fluorouracil—head and neck cancer	0.000548	0.0024	CcSEcCtD
Valproic Acid—Hyponatraemia—Docetaxel—head and neck cancer	0.000546	0.0024	CcSEcCtD
Valproic Acid—Sinusitis—Fluorouracil—head and neck cancer	0.000545	0.00239	CcSEcCtD
Valproic Acid—Agranulocytosis—Fluorouracil—head and neck cancer	0.000542	0.00238	CcSEcCtD
Valproic Acid—Anorexia—Vinblastine—head and neck cancer	0.000538	0.00236	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000533	0.00234	CcSEcCtD
Valproic Acid—Discomfort—Hydroxyurea—head and neck cancer	0.000531	0.00233	CcSEcCtD
Valproic Acid—Haemoglobin—Fluorouracil—head and neck cancer	0.000524	0.0023	CcSEcCtD
Valproic Acid—Rhinitis—Fluorouracil—head and neck cancer	0.000523	0.00229	CcSEcCtD
Valproic Acid—Haemorrhage—Fluorouracil—head and neck cancer	0.000521	0.00229	CcSEcCtD
Valproic Acid—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000519	0.00228	CcSEcCtD
Valproic Acid—Pharyngitis—Fluorouracil—head and neck cancer	0.000518	0.00227	CcSEcCtD
Valproic Acid—Oedema—Hydroxyurea—head and neck cancer	0.000515	0.00226	CcSEcCtD
Valproic Acid—Ataxia—Docetaxel—head and neck cancer	0.000512	0.00224	CcSEcCtD
Valproic Acid—Infection—Hydroxyurea—head and neck cancer	0.000511	0.00224	CcSEcCtD
Valproic Acid—Paraesthesia—Vinblastine—head and neck cancer	0.000507	0.00222	CcSEcCtD
Valproic Acid—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000505	0.00221	CcSEcCtD
Valproic Acid—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000504	0.00221	CcSEcCtD
Valproic Acid—Skin disorder—Hydroxyurea—head and neck cancer	0.0005	0.00219	CcSEcCtD
Valproic Acid—Dry skin—Docetaxel—head and neck cancer	0.000499	0.00219	CcSEcCtD
Valproic Acid—Abdominal pain upper—Docetaxel—head and neck cancer	0.000497	0.00218	CcSEcCtD
Valproic Acid—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000497	0.00218	CcSEcCtD
Valproic Acid—Breast disorder—Docetaxel—head and neck cancer	0.000492	0.00216	CcSEcCtD
Valproic Acid—SLC22A5—trachea—head and neck cancer	0.000492	0.00577	CbGeAlD
Valproic Acid—Anorexia—Hydroxyurea—head and neck cancer	0.000491	0.00215	CcSEcCtD
Valproic Acid—Decreased appetite—Vinblastine—head and neck cancer	0.000491	0.00215	CcSEcCtD
Valproic Acid—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00049	0.00215	CcSEcCtD
Valproic Acid—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00049	0.00215	CcSEcCtD
Valproic Acid—Constipation—Vinblastine—head and neck cancer	0.000483	0.00212	CcSEcCtD
Valproic Acid—Pain—Vinblastine—head and neck cancer	0.000483	0.00212	CcSEcCtD
Valproic Acid—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00048	0.0021	CcSEcCtD
Valproic Acid—HDAC2—lymph node—head and neck cancer	0.000476	0.00558	CbGeAlD
Valproic Acid—Dysphagia—Docetaxel—head and neck cancer	0.00047	0.00206	CcSEcCtD
Valproic Acid—Arrhythmia—Fluorouracil—head and neck cancer	0.000466	0.00204	CcSEcCtD
Valproic Acid—Feeling abnormal—Vinblastine—head and neck cancer	0.000465	0.00204	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000462	0.00202	CcSEcCtD
Valproic Acid—Alopecia—Fluorouracil—head and neck cancer	0.000461	0.00202	CcSEcCtD
Valproic Acid—PTGS1—connective tissue—head and neck cancer	0.00046	0.0054	CbGeAlD
Valproic Acid—Dyspnoea—Hydroxyurea—head and neck cancer	0.000459	0.00201	CcSEcCtD
Valproic Acid—Somnolence—Hydroxyurea—head and neck cancer	0.000458	0.00201	CcSEcCtD
Valproic Acid—SLC22A8—head—head and neck cancer	0.000456	0.00536	CbGeAlD
Valproic Acid—Dyspepsia—Hydroxyurea—head and neck cancer	0.000453	0.00199	CcSEcCtD
Valproic Acid—Decreased appetite—Hydroxyurea—head and neck cancer	0.000447	0.00196	CcSEcCtD
Valproic Acid—Pancytopenia—Docetaxel—head and neck cancer	0.000447	0.00196	CcSEcCtD
Valproic Acid—Abdominal pain—Vinblastine—head and neck cancer	0.000446	0.00196	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000444	0.00195	CcSEcCtD
Valproic Acid—Fatigue—Hydroxyurea—head and neck cancer	0.000444	0.00195	CcSEcCtD
Valproic Acid—Pain—Hydroxyurea—head and neck cancer	0.00044	0.00193	CcSEcCtD
Valproic Acid—Constipation—Hydroxyurea—head and neck cancer	0.00044	0.00193	CcSEcCtD
Valproic Acid—Neutropenia—Docetaxel—head and neck cancer	0.00044	0.00193	CcSEcCtD
Valproic Acid—PTGS1—epithelium—head and neck cancer	0.000436	0.00512	CbGeAlD
Valproic Acid—Weight increased—Docetaxel—head and neck cancer	0.000428	0.00188	CcSEcCtD
Valproic Acid—Vision blurred—Fluorouracil—head and neck cancer	0.000428	0.00188	CcSEcCtD
Valproic Acid—Weight decreased—Docetaxel—head and neck cancer	0.000425	0.00187	CcSEcCtD
Valproic Acid—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000424	0.00186	CcSEcCtD
Valproic Acid—SLC16A1—lymph node—head and neck cancer	0.000423	0.00496	CbGeAlD
Valproic Acid—Pneumonia—Docetaxel—head and neck cancer	0.000422	0.00185	CcSEcCtD
Valproic Acid—Anaemia—Fluorouracil—head and neck cancer	0.00042	0.00184	CcSEcCtD
Valproic Acid—Hypersensitivity—Vinblastine—head and neck cancer	0.000416	0.00182	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000416	0.00182	CcSEcCtD
Valproic Acid—Stomatitis—Docetaxel—head and neck cancer	0.000409	0.00179	CcSEcCtD
Valproic Acid—Conjunctivitis—Docetaxel—head and neck cancer	0.000408	0.00179	CcSEcCtD
Valproic Acid—Body temperature increased—Hydroxyurea—head and neck cancer	0.000407	0.00178	CcSEcCtD
Valproic Acid—Leukopenia—Fluorouracil—head and neck cancer	0.000406	0.00178	CcSEcCtD
Valproic Acid—Asthenia—Vinblastine—head and neck cancer	0.000405	0.00178	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000397	0.00174	CcSEcCtD
Valproic Acid—Epistaxis—Docetaxel—head and neck cancer	0.000395	0.00173	CcSEcCtD
Valproic Acid—Agranulocytosis—Docetaxel—head and neck cancer	0.000391	0.00172	CcSEcCtD
Valproic Acid—SLC22A5—thyroid gland—head and neck cancer	0.000389	0.00456	CbGeAlD
Valproic Acid—Chest pain—Fluorouracil—head and neck cancer	0.000386	0.00169	CcSEcCtD
Valproic Acid—Myalgia—Fluorouracil—head and neck cancer	0.000386	0.00169	CcSEcCtD
Valproic Acid—Diarrhoea—Vinblastine—head and neck cancer	0.000386	0.00169	CcSEcCtD
Valproic Acid—PTGS1—trachea—head and neck cancer	0.000386	0.00453	CbGeAlD
Valproic Acid—Discomfort—Fluorouracil—head and neck cancer	0.000382	0.00167	CcSEcCtD
Valproic Acid—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000379	0.00166	CcSEcCtD
Valproic Acid—Haemoglobin—Docetaxel—head and neck cancer	0.000378	0.00166	CcSEcCtD
Valproic Acid—Rhinitis—Docetaxel—head and neck cancer	0.000377	0.00165	CcSEcCtD
Valproic Acid—Haemorrhage—Docetaxel—head and neck cancer	0.000376	0.00165	CcSEcCtD
Valproic Acid—Hypoaesthesia—Docetaxel—head and neck cancer	0.000375	0.00164	CcSEcCtD
Valproic Acid—Confusional state—Fluorouracil—head and neck cancer	0.000374	0.00164	CcSEcCtD
Valproic Acid—Pharyngitis—Docetaxel—head and neck cancer	0.000374	0.00164	CcSEcCtD
Valproic Acid—Dizziness—Vinblastine—head and neck cancer	0.000373	0.00164	CcSEcCtD
Valproic Acid—CYP2B6—lymphoid tissue—head and neck cancer	0.000372	0.00436	CbGeAlD
Valproic Acid—Urinary tract disorder—Docetaxel—head and neck cancer	0.000372	0.00163	CcSEcCtD
Valproic Acid—Oedema peripheral—Docetaxel—head and neck cancer	0.000371	0.00163	CcSEcCtD
Valproic Acid—Oedema—Fluorouracil—head and neck cancer	0.00037	0.00162	CcSEcCtD
Valproic Acid—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00037	0.00162	CcSEcCtD
Valproic Acid—Connective tissue disorder—Docetaxel—head and neck cancer	0.00037	0.00162	CcSEcCtD
Valproic Acid—Asthenia—Hydroxyurea—head and neck cancer	0.000369	0.00162	CcSEcCtD
Valproic Acid—Urethral disorder—Docetaxel—head and neck cancer	0.000369	0.00162	CcSEcCtD
Valproic Acid—Infection—Fluorouracil—head and neck cancer	0.000368	0.00161	CcSEcCtD
Valproic Acid—Nervous system disorder—Fluorouracil—head and neck cancer	0.000363	0.00159	CcSEcCtD
Valproic Acid—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000363	0.00159	CcSEcCtD
Valproic Acid—Visual impairment—Docetaxel—head and neck cancer	0.000363	0.00159	CcSEcCtD
Valproic Acid—Tachycardia—Fluorouracil—head and neck cancer	0.000362	0.00159	CcSEcCtD
Valproic Acid—Vomiting—Vinblastine—head and neck cancer	0.000359	0.00157	CcSEcCtD
Valproic Acid—Erythema multiforme—Docetaxel—head and neck cancer	0.000356	0.00156	CcSEcCtD
Valproic Acid—Headache—Vinblastine—head and neck cancer	0.000354	0.00155	CcSEcCtD
Valproic Acid—Anorexia—Fluorouracil—head and neck cancer	0.000353	0.00155	CcSEcCtD
Valproic Acid—CYP1A2—thyroid gland—head and neck cancer	0.000352	0.00414	CbGeAlD
Valproic Acid—Diarrhoea—Hydroxyurea—head and neck cancer	0.000352	0.00154	CcSEcCtD
Valproic Acid—Eye disorder—Docetaxel—head and neck cancer	0.000352	0.00154	CcSEcCtD
Valproic Acid—Hypotension—Fluorouracil—head and neck cancer	0.000346	0.00152	CcSEcCtD
Valproic Acid—Angiopathy—Docetaxel—head and neck cancer	0.000341	0.0015	CcSEcCtD
Valproic Acid—Dizziness—Hydroxyurea—head and neck cancer	0.00034	0.00149	CcSEcCtD
Valproic Acid—Immune system disorder—Docetaxel—head and neck cancer	0.00034	0.00149	CcSEcCtD
Valproic Acid—Mediastinal disorder—Docetaxel—head and neck cancer	0.000339	0.00149	CcSEcCtD
Valproic Acid—Chills—Docetaxel—head and neck cancer	0.000338	0.00148	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000338	0.00148	CcSEcCtD
Valproic Acid—Arrhythmia—Docetaxel—head and neck cancer	0.000336	0.00147	CcSEcCtD
Valproic Acid—Nausea—Vinblastine—head and neck cancer	0.000335	0.00147	CcSEcCtD
Valproic Acid—Insomnia—Fluorouracil—head and neck cancer	0.000335	0.00147	CcSEcCtD
Valproic Acid—Paraesthesia—Fluorouracil—head and neck cancer	0.000333	0.00146	CcSEcCtD
Valproic Acid—Alopecia—Docetaxel—head and neck cancer	0.000333	0.00146	CcSEcCtD
Valproic Acid—Dyspnoea—Fluorouracil—head and neck cancer	0.00033	0.00145	CcSEcCtD
Valproic Acid—Mental disorder—Docetaxel—head and neck cancer	0.00033	0.00145	CcSEcCtD
Valproic Acid—Somnolence—Fluorouracil—head and neck cancer	0.000329	0.00144	CcSEcCtD
Valproic Acid—Malnutrition—Docetaxel—head and neck cancer	0.000328	0.00144	CcSEcCtD
Valproic Acid—Vomiting—Hydroxyurea—head and neck cancer	0.000327	0.00144	CcSEcCtD
Valproic Acid—Dyspepsia—Fluorouracil—head and neck cancer	0.000326	0.00143	CcSEcCtD
Valproic Acid—Rash—Hydroxyurea—head and neck cancer	0.000325	0.00142	CcSEcCtD
Valproic Acid—Dermatitis—Hydroxyurea—head and neck cancer	0.000324	0.00142	CcSEcCtD
Valproic Acid—Headache—Hydroxyurea—head and neck cancer	0.000322	0.00141	CcSEcCtD
Valproic Acid—Decreased appetite—Fluorouracil—head and neck cancer	0.000322	0.00141	CcSEcCtD
Valproic Acid—Dysgeusia—Docetaxel—head and neck cancer	0.000321	0.00141	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00032	0.0014	CcSEcCtD
Valproic Acid—Back pain—Docetaxel—head and neck cancer	0.000317	0.00139	CcSEcCtD
Valproic Acid—Pain—Fluorouracil—head and neck cancer	0.000317	0.00139	CcSEcCtD
Valproic Acid—Muscle spasms—Docetaxel—head and neck cancer	0.000315	0.00138	CcSEcCtD
Valproic Acid—Nausea—Hydroxyurea—head and neck cancer	0.000306	0.00134	CcSEcCtD
Valproic Acid—PTGS1—thyroid gland—head and neck cancer	0.000305	0.00358	CbGeAlD
Valproic Acid—Feeling abnormal—Fluorouracil—head and neck cancer	0.000305	0.00134	CcSEcCtD
Valproic Acid—Anaemia—Docetaxel—head and neck cancer	0.000303	0.00133	CcSEcCtD
Valproic Acid—CYP2B6—head—head and neck cancer	0.0003	0.00352	CbGeAlD
Valproic Acid—Urticaria—Fluorouracil—head and neck cancer	0.000294	0.00129	CcSEcCtD
Valproic Acid—Leukopenia—Docetaxel—head and neck cancer	0.000293	0.00129	CcSEcCtD
Valproic Acid—Body temperature increased—Fluorouracil—head and neck cancer	0.000293	0.00128	CcSEcCtD
Valproic Acid—Palpitations—Docetaxel—head and neck cancer	0.00029	0.00127	CcSEcCtD
Valproic Acid—Cough—Docetaxel—head and neck cancer	0.000286	0.00125	CcSEcCtD
Valproic Acid—Hypertension—Docetaxel—head and neck cancer	0.000283	0.00124	CcSEcCtD
Valproic Acid—Chest pain—Docetaxel—head and neck cancer	0.000279	0.00122	CcSEcCtD
Valproic Acid—Myalgia—Docetaxel—head and neck cancer	0.000279	0.00122	CcSEcCtD
Valproic Acid—Arthralgia—Docetaxel—head and neck cancer	0.000279	0.00122	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000277	0.00121	CcSEcCtD
Valproic Acid—Hypersensitivity—Fluorouracil—head and neck cancer	0.000273	0.0012	CcSEcCtD
Valproic Acid—Dry mouth—Docetaxel—head and neck cancer	0.000273	0.0012	CcSEcCtD
Valproic Acid—PTGS1—head—head and neck cancer	0.000271	0.00318	CbGeAlD
Valproic Acid—Confusional state—Docetaxel—head and neck cancer	0.00027	0.00118	CcSEcCtD
Valproic Acid—Oedema—Docetaxel—head and neck cancer	0.000267	0.00117	CcSEcCtD
Valproic Acid—Anaphylactic shock—Docetaxel—head and neck cancer	0.000267	0.00117	CcSEcCtD
Valproic Acid—Infection—Docetaxel—head and neck cancer	0.000266	0.00116	CcSEcCtD
Valproic Acid—Nervous system disorder—Docetaxel—head and neck cancer	0.000262	0.00115	CcSEcCtD
Valproic Acid—Pruritus—Fluorouracil—head and neck cancer	0.000262	0.00115	CcSEcCtD
Valproic Acid—Thrombocytopenia—Docetaxel—head and neck cancer	0.000262	0.00115	CcSEcCtD
Valproic Acid—Tachycardia—Docetaxel—head and neck cancer	0.000261	0.00114	CcSEcCtD
Valproic Acid—Skin disorder—Docetaxel—head and neck cancer	0.00026	0.00114	CcSEcCtD
Valproic Acid—Anorexia—Docetaxel—head and neck cancer	0.000255	0.00112	CcSEcCtD
Valproic Acid—Diarrhoea—Fluorouracil—head and neck cancer	0.000253	0.00111	CcSEcCtD
Valproic Acid—Hypotension—Docetaxel—head and neck cancer	0.00025	0.0011	CcSEcCtD
Valproic Acid—Dizziness—Fluorouracil—head and neck cancer	0.000245	0.00107	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000244	0.00107	CcSEcCtD
Valproic Acid—Insomnia—Docetaxel—head and neck cancer	0.000242	0.00106	CcSEcCtD
Valproic Acid—SLC22A5—lymph node—head and neck cancer	0.000242	0.00284	CbGeAlD
Valproic Acid—Paraesthesia—Docetaxel—head and neck cancer	0.00024	0.00105	CcSEcCtD
Valproic Acid—Dyspnoea—Docetaxel—head and neck cancer	0.000238	0.00105	CcSEcCtD
Valproic Acid—Somnolence—Docetaxel—head and neck cancer	0.000238	0.00104	CcSEcCtD
Valproic Acid—Vomiting—Fluorouracil—head and neck cancer	0.000236	0.00103	CcSEcCtD
Valproic Acid—Dyspepsia—Docetaxel—head and neck cancer	0.000235	0.00103	CcSEcCtD
Valproic Acid—Rash—Fluorouracil—head and neck cancer	0.000234	0.00102	CcSEcCtD
Valproic Acid—Dermatitis—Fluorouracil—head and neck cancer	0.000233	0.00102	CcSEcCtD
Valproic Acid—Decreased appetite—Docetaxel—head and neck cancer	0.000232	0.00102	CcSEcCtD
Valproic Acid—Headache—Fluorouracil—head and neck cancer	0.000232	0.00102	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000231	0.00101	CcSEcCtD
Valproic Acid—Fatigue—Docetaxel—head and neck cancer	0.000231	0.00101	CcSEcCtD
Valproic Acid—Pain—Docetaxel—head and neck cancer	0.000229	0.001	CcSEcCtD
Valproic Acid—Constipation—Docetaxel—head and neck cancer	0.000229	0.001	CcSEcCtD
Valproic Acid—Feeling abnormal—Docetaxel—head and neck cancer	0.00022	0.000966	CcSEcCtD
Valproic Acid—Nausea—Fluorouracil—head and neck cancer	0.00022	0.000965	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000219	0.000959	CcSEcCtD
Valproic Acid—Body temperature increased—Docetaxel—head and neck cancer	0.000211	0.000927	CcSEcCtD
Valproic Acid—Abdominal pain—Docetaxel—head and neck cancer	0.000211	0.000927	CcSEcCtD
Valproic Acid—Hypersensitivity—Docetaxel—head and neck cancer	0.000197	0.000864	CcSEcCtD
Valproic Acid—Asthenia—Docetaxel—head and neck cancer	0.000192	0.000841	CcSEcCtD
Valproic Acid—PTGS1—lymph node—head and neck cancer	0.00019	0.00223	CbGeAlD
Valproic Acid—Pruritus—Docetaxel—head and neck cancer	0.000189	0.00083	CcSEcCtD
Valproic Acid—Diarrhoea—Docetaxel—head and neck cancer	0.000183	0.000802	CcSEcCtD
Valproic Acid—Dizziness—Docetaxel—head and neck cancer	0.000177	0.000775	CcSEcCtD
Valproic Acid—Vomiting—Docetaxel—head and neck cancer	0.00017	0.000746	CcSEcCtD
Valproic Acid—Rash—Docetaxel—head and neck cancer	0.000169	0.000739	CcSEcCtD
Valproic Acid—Dermatitis—Docetaxel—head and neck cancer	0.000168	0.000739	CcSEcCtD
Valproic Acid—Headache—Docetaxel—head and neck cancer	0.000168	0.000735	CcSEcCtD
Valproic Acid—Nausea—Docetaxel—head and neck cancer	0.000159	0.000696	CcSEcCtD
Valproic Acid—UGT1A9—Metabolism—YAP1—head and neck cancer	4.66e-05	0.000252	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—GPX1—head and neck cancer	4.61e-05	0.00025	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—AKT1—head and neck cancer	4.61e-05	0.00025	CbGpPWpGaD
Valproic Acid—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	4.57e-05	0.000247	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—CYP1A1—head and neck cancer	4.56e-05	0.000247	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—NAT2—head and neck cancer	4.56e-05	0.000247	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—MAPK3—head and neck cancer	4.54e-05	0.000246	CbGpPWpGaD
Valproic Acid—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	4.51e-05	0.000244	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.48e-05	0.000243	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—MAPK3—head and neck cancer	4.44e-05	0.000241	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—TYMS—head and neck cancer	4.34e-05	0.000235	CbGpPWpGaD
Valproic Acid—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	4.33e-05	0.000235	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—AKT1—head and neck cancer	4.33e-05	0.000234	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—MAPK1—head and neck cancer	4.32e-05	0.000234	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—EGFR—head and neck cancer	4.32e-05	0.000234	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—NAT2—head and neck cancer	4.31e-05	0.000234	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—VEGFA—head and neck cancer	4.3e-05	0.000233	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—GSTM1—head and neck cancer	4.29e-05	0.000232	CbGpPWpGaD
Valproic Acid—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	4.27e-05	0.000231	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—MAPK1—head and neck cancer	4.23e-05	0.000229	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—PTGS2—head and neck cancer	4.21e-05	0.000228	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—PTEN—head and neck cancer	4.2e-05	0.000227	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—GPX1—head and neck cancer	4.11e-05	0.000222	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—CYP1A1—head and neck cancer	4.07e-05	0.00022	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—MAPK3—head and neck cancer	4.06e-05	0.00022	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—TYMS—head and neck cancer	4.05e-05	0.000219	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—GSTM1—head and neck cancer	4e-05	0.000217	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—DPYD—head and neck cancer	4e-05	0.000217	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—IL2—head and neck cancer	3.95e-05	0.000214	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—AKT1—head and neck cancer	3.92e-05	0.000212	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—MAPK1—head and neck cancer	3.87e-05	0.000209	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CCND1—head and neck cancer	3.85e-05	0.000209	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—GPX1—head and neck cancer	3.83e-05	0.000207	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—NOTCH1—head and neck cancer	3.83e-05	0.000207	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	3.83e-05	0.000207	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—UROD—head and neck cancer	3.81e-05	0.000206	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—YAP1—head and neck cancer	3.8e-05	0.000206	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—CYP1A1—head and neck cancer	3.79e-05	0.000205	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—DPYD—head and neck cancer	3.78e-05	0.000205	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—PIK3CA—head and neck cancer	3.75e-05	0.000203	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—PTEN—head and neck cancer	3.72e-05	0.000201	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—PTEN—head and neck cancer	3.67e-05	0.000199	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—PIK3CA—head and neck cancer	3.67e-05	0.000199	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—YAP1—head and neck cancer	3.59e-05	0.000194	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—NOTCH1—head and neck cancer	3.56e-05	0.000193	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—TP53—head and neck cancer	3.55e-05	0.000192	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—TYMS—head and neck cancer	3.54e-05	0.000192	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PTGS2—head and neck cancer	3.51e-05	0.00019	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.5e-05	0.000189	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—GSTM1—head and neck cancer	3.5e-05	0.000189	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—NAT2—head and neck cancer	3.48e-05	0.000189	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—HRAS—head and neck cancer	3.47e-05	0.000188	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—TYMS—head and neck cancer	3.44e-05	0.000186	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—NAT2—head and neck cancer	3.4e-05	0.000184	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—GSTM1—head and neck cancer	3.4e-05	0.000184	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—HRAS—head and neck cancer	3.39e-05	0.000184	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—VEGFA—head and neck cancer	3.36e-05	0.000182	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—PIK3CA—head and neck cancer	3.36e-05	0.000182	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—GPX1—head and neck cancer	3.35e-05	0.000181	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—STAT3—head and neck cancer	3.33e-05	0.00018	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—CYP1A1—head and neck cancer	3.31e-05	0.00018	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—GPX1—head and neck cancer	3.26e-05	0.000176	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—TP53—head and neck cancer	3.25e-05	0.000176	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—CYP1A1—head and neck cancer	3.22e-05	0.000175	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—MAPK3—head and neck cancer	3.18e-05	0.000172	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.13e-05	0.000169	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—HRAS—head and neck cancer	3.1e-05	0.000168	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.1e-05	0.000168	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PTEN—head and neck cancer	3.06e-05	0.000166	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—AKT1—head and neck cancer	3.06e-05	0.000166	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—DPYD—head and neck cancer	3.05e-05	0.000165	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.05e-05	0.000165	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—MAPK1—head and neck cancer	3.02e-05	0.000164	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—EGFR—head and neck cancer	3.02e-05	0.000164	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—AKT1—head and neck cancer	3e-05	0.000162	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—DPYD—head and neck cancer	2.98e-05	0.000162	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—PIK3CA—head and neck cancer	2.96e-05	0.00016	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—NAT2—head and neck cancer	2.95e-05	0.00016	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—YAP1—head and neck cancer	2.9e-05	0.000157	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.85e-05	0.000154	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—YAP1—head and neck cancer	2.83e-05	0.000153	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—TYMS—head and neck cancer	2.8e-05	0.000151	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.79e-05	0.000151	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.77e-05	0.00015	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—GSTM1—head and neck cancer	2.76e-05	0.00015	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—AKT1—head and neck cancer	2.74e-05	0.000148	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PTGS2—head and neck cancer	2.71e-05	0.000147	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—GPX1—head and neck cancer	2.65e-05	0.000143	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PTGS2—head and neck cancer	2.64e-05	0.000143	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—NAT2—head and neck cancer	2.63e-05	0.000142	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—PIK3CA—head and neck cancer	2.62e-05	0.000142	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—CYP1A1—head and neck cancer	2.62e-05	0.000142	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—PIK3CA—head and neck cancer	2.59e-05	0.00014	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—DPYD—head and neck cancer	2.58e-05	0.00014	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.55e-05	0.000138	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TP53—head and neck cancer	2.54e-05	0.000137	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.52e-05	0.000137	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NOTCH1—head and neck cancer	2.49e-05	0.000135	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.49e-05	0.000135	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—YAP1—head and neck cancer	2.45e-05	0.000133	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HRAS—head and neck cancer	2.43e-05	0.000131	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—AKT1—head and neck cancer	2.42e-05	0.000131	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PTGS2—head and neck cancer	2.42e-05	0.000131	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—NAT2—head and neck cancer	2.4e-05	0.00013	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PTEN—head and neck cancer	2.37e-05	0.000128	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—DPYD—head and neck cancer	2.31e-05	0.000125	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PTEN—head and neck cancer	2.3e-05	0.000125	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—TYMS—head and neck cancer	2.28e-05	0.000123	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PTGS2—head and neck cancer	2.26e-05	0.000122	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—GSTM1—head and neck cancer	2.25e-05	0.000122	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—YAP1—head and neck cancer	2.19e-05	0.000119	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.18e-05	0.000118	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PIK3CA—head and neck cancer	2.16e-05	0.000117	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—GPX1—head and neck cancer	2.16e-05	0.000117	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—TYMS—head and neck cancer	2.16e-05	0.000117	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.15e-05	0.000117	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.15e-05	0.000117	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—AKT1—head and neck cancer	2.14e-05	0.000116	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CYP1A1—head and neck cancer	2.14e-05	0.000116	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GSTM1—head and neck cancer	2.13e-05	0.000115	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—MAPK3—head and neck cancer	2.12e-05	0.000115	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—AKT1—head and neck cancer	2.12e-05	0.000115	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PTEN—head and neck cancer	2.11e-05	0.000114	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—DPYD—head and neck cancer	2.1e-05	0.000114	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—STAT3—head and neck cancer	2.06e-05	0.000112	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—NAT2—head and neck cancer	2.05e-05	0.000111	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GPX1—head and neck cancer	2.04e-05	0.000111	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CYP1A1—head and neck cancer	2.02e-05	0.000109	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—YAP1—head and neck cancer	2e-05	0.000108	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PTGS2—head and neck cancer	1.97e-05	0.000107	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MAPK3—head and neck cancer	1.97e-05	0.000107	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PTEN—head and neck cancer	1.97e-05	0.000107	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PTGS2—head and neck cancer	1.92e-05	0.000104	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MAPK1—head and neck cancer	1.87e-05	0.000101	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—EGFR—head and neck cancer	1.87e-05	0.000101	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.84e-05	9.98e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—DPYD—head and neck cancer	1.8e-05	9.73e-05	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—AKT1—head and neck cancer	1.77e-05	9.56e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.75e-05	9.5e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—TYMS—head and neck cancer	1.74e-05	9.42e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GSTM1—head and neck cancer	1.72e-05	9.31e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PTEN—head and neck cancer	1.72e-05	9.31e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL2—head and neck cancer	1.71e-05	9.28e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—YAP1—head and neck cancer	1.71e-05	9.24e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—TYMS—head and neck cancer	1.7e-05	9.21e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GSTM1—head and neck cancer	1.68e-05	9.1e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PTEN—head and neck cancer	1.67e-05	9.06e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CCND1—head and neck cancer	1.67e-05	9.05e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PIK3CA—head and neck cancer	1.67e-05	9.04e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GPX1—head and neck cancer	1.65e-05	8.92e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.64e-05	8.91e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CYP1A1—head and neck cancer	1.63e-05	8.83e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PIK3CA—head and neck cancer	1.62e-05	8.8e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PTEN—head and neck cancer	1.61e-05	8.73e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GPX1—head and neck cancer	1.61e-05	8.71e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.61e-05	8.7e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CYP1A1—head and neck cancer	1.59e-05	8.63e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—NAT2—head and neck cancer	1.58e-05	8.57e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTGS2—head and neck cancer	1.56e-05	8.44e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—HRAS—head and neck cancer	1.5e-05	8.14e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.5e-05	8.12e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PIK3CA—head and neck cancer	1.49e-05	8.06e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—TYMS—head and neck cancer	1.47e-05	7.97e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—VEGFA—head and neck cancer	1.46e-05	7.89e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GSTM1—head and neck cancer	1.46e-05	7.88e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—STAT3—head and neck cancer	1.44e-05	7.81e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.43e-05	7.77e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—AKT1—head and neck cancer	1.43e-05	7.74e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GPX1—head and neck cancer	1.39e-05	7.55e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PIK3CA—head and neck cancer	1.39e-05	7.51e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—DPYD—head and neck cancer	1.39e-05	7.51e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CYP1A1—head and neck cancer	1.38e-05	7.47e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MAPK3—head and neck cancer	1.38e-05	7.46e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—AKT1—head and neck cancer	1.36e-05	7.38e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTEN—head and neck cancer	1.36e-05	7.36e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—AKT1—head and neck cancer	1.33e-05	7.19e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—YAP1—head and neck cancer	1.32e-05	7.13e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—TYMS—head and neck cancer	1.31e-05	7.12e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MAPK1—head and neck cancer	1.31e-05	7.1e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EGFR—head and neck cancer	1.31e-05	7.1e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.31e-05	7.08e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GSTM1—head and neck cancer	1.3e-05	7.04e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.28e-05	6.94e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTGS2—head and neck cancer	1.27e-05	6.88e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GPX1—head and neck cancer	1.24e-05	6.74e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CYP1A1—head and neck cancer	1.23e-05	6.67e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—AKT1—head and neck cancer	1.22e-05	6.58e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PIK3CA—head and neck cancer	1.21e-05	6.57e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTGS2—head and neck cancer	1.2e-05	6.51e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—TYMS—head and neck cancer	1.2e-05	6.49e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GSTM1—head and neck cancer	1.18e-05	6.41e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PIK3CA—head and neck cancer	1.18e-05	6.39e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PIK3CA—head and neck cancer	1.14e-05	6.16e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GPX1—head and neck cancer	1.13e-05	6.14e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.13e-05	6.14e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—AKT1—head and neck cancer	1.13e-05	6.14e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.12e-05	6.08e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.12e-05	6.05e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTEN—head and neck cancer	1.11e-05	6e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TP53—head and neck cancer	1.1e-05	5.96e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HRAS—head and neck cancer	1.05e-05	5.7e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTEN—head and neck cancer	1.05e-05	5.67e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—TYMS—head and neck cancer	1.02e-05	5.55e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.01e-05	5.48e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.01e-05	5.48e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—AKT1—head and neck cancer	9.91e-06	5.37e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GPX1—head and neck cancer	9.69e-06	5.25e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTGS2—head and neck cancer	9.69e-06	5.25e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—AKT1—head and neck cancer	9.64e-06	5.22e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP1A1—head and neck cancer	9.6e-06	5.2e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PIK3CA—head and neck cancer	9.59e-06	5.19e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTGS2—head and neck cancer	9.47e-06	5.13e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—AKT1—head and neck cancer	9.29e-06	5.03e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	9.22e-06	5e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTEN—head and neck cancer	8.45e-06	4.58e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTEN—head and neck cancer	8.26e-06	4.47e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTGS2—head and neck cancer	8.2e-06	4.44e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—TYMS—head and neck cancer	7.9e-06	4.28e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.88e-06	4.27e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—AKT1—head and neck cancer	7.83e-06	4.24e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CA—head and neck cancer	7.81e-06	4.23e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GSTM1—head and neck cancer	7.81e-06	4.23e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GPX1—head and neck cancer	7.48e-06	4.05e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP1A1—head and neck cancer	7.41e-06	4.01e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CA—head and neck cancer	7.39e-06	4e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTGS2—head and neck cancer	7.32e-06	3.97e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTEN—head and neck cancer	7.16e-06	3.88e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTGS2—head and neck cancer	6.68e-06	3.62e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTEN—head and neck cancer	6.39e-06	3.46e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—AKT1—head and neck cancer	6.38e-06	3.46e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—AKT1—head and neck cancer	6.04e-06	3.27e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CA—head and neck cancer	5.96e-06	3.23e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CA—head and neck cancer	5.83e-06	3.16e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTEN—head and neck cancer	5.82e-06	3.15e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTGS2—head and neck cancer	5.71e-06	3.09e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CA—head and neck cancer	5.05e-06	2.73e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTEN—head and neck cancer	4.98e-06	2.7e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—AKT1—head and neck cancer	4.87e-06	2.64e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—AKT1—head and neck cancer	4.76e-06	2.58e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CA—head and neck cancer	4.51e-06	2.44e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTGS2—head and neck cancer	4.4e-06	2.39e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—AKT1—head and neck cancer	4.12e-06	2.23e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CA—head and neck cancer	4.11e-06	2.23e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTEN—head and neck cancer	3.84e-06	2.08e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—AKT1—head and neck cancer	3.68e-06	1.99e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CA—head and neck cancer	3.51e-06	1.9e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—AKT1—head and neck cancer	3.36e-06	1.82e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—AKT1—head and neck cancer	2.87e-06	1.55e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2.71e-06	1.47e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AKT1—head and neck cancer	2.21e-06	1.2e-05	CbGpPWpGaD
